China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research note issued on Saturday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

China Pharma stock opened at $0.32 on Friday. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.48. China Pharma has a 12 month low of $0.30 and a 12 month high of $2.70. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.33 and a current ratio of 0.88.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.